Neuromodulation for lower urinary tract dysfunction--an update.
The aim of this review is to provide an update on the use of neuromodulation using sacral nerve stimulation for the treatment of disorders of the lower urinary tract. Neuromodulation using the InterStim system (Medtronic Inc.) is now accepted as an established therapeutic option for patients with detrusor overactivity, and for women with retention or severe voiding difficulties. However, the use of nerve stimulation in modulating lower urinary tract function has to be regarded as a technique that is in its infancy. Much has yet to be learned about the mechanism by which neuromodulation exerts its effects and there is a need to better define the clinical indications for the treatment. There is also work to be done in terms of optimising stimulation delivery, both in anatomical and electronic terms.
Hussain
Zahid
Z
Department of Urology, Pinderfields General Hospital, Wakefield, UK. zahid@doctors.org.uk
Harrison
Simon C W
SC
D002986:Clinical Trials as Topic / Q000639:trends; D004599:Electric Stimulation Therapy / Q000295:instrumentation* / Q000379:methods / Q000639:trends*; D005544:Forecasting; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000534:rehabilitation*